Construction and characterization of bivalent vaccine candidate expressing HspA and Mr18000 OMP from Helicobacter pylori

doi:10.3748/wjg.v9.i8.1756

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3255)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

391

HTML

2692

Figures (1-6)

172

Sum=3255

Aug 15, 2003 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

H. Pylori

World J Gastroenterol. Aug 15, 2003; 9(8): 1756-1761
Published online Aug 15, 2003. doi: 10.3748/wjg.v9.i8.1756

Full Size Figure Download Figure

Figure 5 150 g·L^-1 SDS-PAGE of total protein in recombinant vector expressed in BL21 E. coli. Lane 1. Standard protein marker (M_r 14; 31; 42; 66; 97 × 10³), Lane 2. Bacterial protein expressed in BL21 after induction for 4 hours with IPTG, Lane 3-7. Ex-pression of recombinant vector in BL21 after induction for 4 h with IPTG.

Citation: Jiang Z, Huang AL, Tao XH, Wang PL. Construction and characterization of bivalent vaccine candidate expressing HspA and M_r18000 OMP from Helicobacter pylori. World J Gastroenterol 2003; 9(8): 1756-1761
URL: https://www.wjgnet.com/1007-9327/full/v9/i8/1756.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i8.1756